Veristat
Veristat, Inc. is a clinical research organization based in Southborough, Massachusetts, with additional offices in North Carolina, California, Canada, the United Kingdom, and Taiwan. Established in 1994, the company specializes in providing a range of clinical development services to pharmaceutical, biotechnology, and medical device companies. These services include biostatistics, statistical programming, medical writing, clinical monitoring, project management, and data management. Veristat supports clients through various stages of clinical trials, offering solutions for advanced study designs, predictive modeling, and regulatory submissions. The firm is dedicated to scientific integrity and client focus, fostering long-lasting relationships with a diverse clientele engaged in developing new pharmaceutical products, vaccines, and medical devices.
SQN Clinical is a specialist biometrics CROs in Europe and is the preferred clinical development partner for many pharmaceutical, biotechnology and animal healthcare companies in the UK, Europe and the rest of world.
Spero Oncology is a clinical research organization focused on the development of oncology products. The company specializes in providing clinical operations support for oncology clinical trials, primarily in Europe, as well as in Australia and New Zealand. By collaborating with Veristat, a full-service CRO with over 20 years of experience, Spero Oncology enhances its capabilities to support pharmaceutical, biotechnology, and medical device firms throughout the clinical trials and regulatory processes. This partnership aims to offer a broader range of services and therapeutic expertise, ultimately assisting in the expedited market introduction of novel therapies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.